Order results by:
| Issue | Title | |
| Vol 13, No 1 (2021) | The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’ | Abstract similar documents |
| V. V. Kovalchuk | ||
| "... manifestations of CCI in patients with a recent experience of COVID-19. Objective: to evaluate Actovegin ..." | ||
| Vol 1, No 1 (2009) | USE OF ACTOVEGIN IN NEUROLOGY | Abstract similar documents |
| Yu. A. Starchina | ||
| "... in many diseases of the central and peripheral nervous system. The use of Actovegin is of great interest ..." | ||
| Vol 13, No 2 (2021) | Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19) | Abstract similar documents |
| V. A. Kutashov | ||
| "... and discussion. Post-COVID patients with CI in the Actovegin group after 60 days follow-up had higher mean MoCА ..." | ||
| Vol 11, No 3 (2019) | Advances in neurometabolic therapy | Abstract similar documents |
| V. V. Zakharov, N. V. Vakhnina | ||
| "... Actovegin is a calf blood extract that contains more than 200 biologically active compounds ..." | ||
| Vol 1, No 3-4 (2009) | COMPLEX THERAPY FOR HYPERTENSIVE AND MIXED ENCEPHALOPATHY | Abstract similar documents |
| S. A. Rumyantseva | ||
| Vol 5, No 3 (2013) | Diabetic peripheral neuropathy therapy-induced activation of humoral serotonin and endogenous neurotrophins | Abstract similar documents |
| Yuulia Vladimirovna Karakulova, N B Kaigorodova, E A Batueva | ||
| "... to normalize carbohydrate metabolism, 30 patients with DPN received actovegin in an intravenous, jetwise dose ..." | ||
| Vol 11, No 4 (2019) | Poststroke cognitive impairment | Abstract similar documents |
| V. A. Parfenov | ||
| "... the progression of CI in stroke patients. The use of Actovegin in patients with CI after stroke is discussed ..." | ||
| Vol 13, No 3 (2021) | Management tactics in patients with chronic cerebral ischemia during COVID-19 pandemic | Abstract PDF (Eng) similar documents |
| A. A. Kulesh | ||
| "... and arterioles. COVID-19 pandemic can modify CCI progression due to similar pathophysiology. In particular, COVID ..." | ||
| Vol 4, No 2 (2012) | Capacities for the drug correction of functional disorders in posthypoxic encephalopathy | Abstract similar documents |
| M M Odinak, A Yu Emelin, V Yu Lobzin, S V Vorobyev | ||
| "... . Обсуждается применение актовегина в комплексной терапии ПЭ. ..." | ||
| Vol 10, No 3 (2018) | Pharmacoeconomic analysis of the use of actovegin in patients with post-stroke cognitive impairment in the health care system of the Russian Federation | Abstract similar documents |
| V. V. Ryazhenov, S. G. Gorokhova, A. V. Knyazev | ||
| "... a comparative pharmacoeconomic analysis of the use of actovegin (Takeda Pharmaceuticals, Switzerland) in Russian ..." | ||
| Vol 5, No 2S (2013): Special issue "Stroke" | Dissection of internal carotid and vertebral arteries: clinical presentation, diagnosis, and treatment | Abstract similar documents |
| Lyudmila Andreevna Kalashnikova | ||
| "... as with trophic drugs, primarily actovegin, in both acute and chronic phases. ..." | ||
| Vol 13, No 1 (2021) | Chronic cerebral ischemia and headache in patients in primary care physician's practice | Abstract similar documents |
| V. N. Shishkova, T. V. Adasheva | ||
| "... Today, chronic cerebral ischemia (CCI) is the most common diagnosis in our country, both ..." | ||
| Vol 10, No 1 (2018) | Headache in elderly patients with chronic cerebral ischemia: outpatient diagnosis and treatment | Abstract similar documents |
| M. P. Platov, O. V. Kosivtsova | ||
| "... Chronic cerebral ischemia (CCI) is one of the most common diagnoses in middle-aged and elderly ..." | ||
| Vol 13, No 1 (2021) | Clinical manifestations and issues of diagnosis of chronic cerebrovascular disease (chronic cerebral ischemia) at an early (pre-dementia) stage | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, A. Yu. Emelin, A. N. Bogolepova, O. B. Doronina, V. V. Zakharov, O. V. Kolokolov, S. V. Kotov, L. L. Korsunskaya, M. A. Kutlubaev, V. B. Laskov, O. S. Levin, V. A. Parfenov | ||
| "... cerebrovascular disease (CVD) (chronic cerebral ischemia (CCI) and dyscirculatory encephalopathy (DEP)) at the pre ..." | ||
| Vol 1, No 2 (2009) | METABOLIC CORRECTION OF NEUROLOGICAL COMPLICATIONS OF DIABETES MELLITUS | Abstract similar documents |
| S. A. Rumyantseva, V. A. Stupin, E. V. Silina, V. V. Mikhal'skiy, A. I. Perevedentsev, D. D. Ryzhova | ||
| "... investigations demonstrating the efficacy of actovegin in the treatment of diabetic polyneuropathy ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy) | Abstract similar documents |
| V. A. Parfenov | ||
| "... in foreign neurological practice, as well as chronic cerebral ischemia (CCI) and dyscirculatory ..." | ||
| Vol 17, No 3 (2025) | Cognitive impairment in patients with chronic cerebral ischemia (discirculatory encephalopathy) | Abstract similar documents |
| V. A. Parfenov, E. V. Silina | ||
| "... Chronic cerebral ischemia (CCI), also known as discirculatory encephalopathy (DE), is one ..." | ||
| Vol 10, No 4 (2018) | Chronic cerebrovascular diseases: use of vinpocetine in neurological practice (Round Table proceedings) | Abstract similar documents |
| V. A. Parfenov, S. A. Zhivolupov, V. V. Zakharov, L. A. Belova, O. V. Lagoda, R. G. Esin, N. V. Vakhnina, I. N. Samartsev | ||
| "... (CCI), or dyscirculatory encephalopathy (DEP), is one of the most common neurological diagnoses in our ..." | ||
| Vol 7, No 4 (2015) | Clinical and etiological associations in chronic cerebral ischemia | Abstract similar documents |
| Yu. V. Zhitkova | ||
| "... Objective: to study the clinical features of chronic cerebral ischemia (CCI) in relation ..." | ||
| Vol 13, No 1 (2021) | Evaluation of the efficacy and tolerability of naftidrofuryl in the therapy of chronic cerebral ischemia | Abstract similar documents |
| M. N. Dadasheva, I. A. Zolotovskaya, R. V. Gorenkov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... ®) in patients with chronic cerebral ischemia (CCI). Patients and methods. A prospective open-label multicenter ..." | ||
| Vol 15, No 2 (2023) | Possibilities of multimodal neuroprotection in patients with chronic cerebral ischemia on the background of arterial hypertension and atherosclerosis | Abstract similar documents |
| I. A. Gribacheva, T. F. Popova, E. V. Petrova, A. V. Zvonkova | ||
| "... ischemia (CCI) on the background of arterial hypertension and atherosclerosis. Material and methods ..." | ||
| Vol 2, No 2 (2010) | Vertebrobasilar insufficiency: clinical and diagnostic aspects | Abstract similar documents |
| S. K. Volkov | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Drug therapy and cognitive stimulation in patients with poststroke cognitive impairments | Abstract similar documents |
| D.R. Khasanova, Yu.V. Zhitkova, L.M. Yu.V. | ||
| "... ) actovegin infusions; 3) cerebrolysin infusions; 4) drug therapy in combination with non-drug cognitive ..." | ||
| Vol 14, No 3 (2022) | Acute and long-term neurological disorders in patients with coronavirus infection | Abstract PDF (Eng) similar documents |
| V. A. Parfenov, A. A. Kulesh | ||
| "... Currently, patients who attribute their complaints and disorders to the past COVID-19 are turning ..." | ||
| Vol 14, No 6 (2022) | Post-COVID syndrome in psychiatric practice | Abstract similar documents |
| N. N. Petrova, E. V. Pryanikova, Y. L. Pustotin, N. V. Yakusheva, M. V. Dorofeikova | ||
| "... disorders, which tend to have a long course in the post-COVID period. Objective: to study post-COVID mental ..." | ||
| Vol 14, No 6 (2022) | Alzheimer's disease and COVID-19 | Abstract similar documents |
| N. N. Koberskaya, F. A. Roshchin | ||
| "... In elderly patients with COVID-19 cognitive functions decline; it has been suggested that SARS-CoV ..." | ||
| Vol 13, No 5 (2021) | Anticoagulant therapy for stroke prevention in patients with severe COVID-19 | Abstract similar documents |
| A. T. Azimov, G. S. Rakhimbaeva, F. Z. Azimov | ||
| "... complications associated with COVID-19. There is no doubt that stroke can be a major complication in patients ..." | ||
| Дисциркуляторная энцефалопатия и сосудистые когнитивные расстройства | Дисциркуляторная энцефалопатия и сосудистые когнитивные расстройства | Abstract similar documents |
| "... настоящее время диагноз дисциркуляторной энцефалопатии (ДЭП) или хронической ишемии головного мозга (ХИГМ ..." | ||
| Vol 15, No 3 (2023) | Resolution of the Council of Experts on the topic “New treatment options for patients with chronic cerebral ischemia”, March 31, 2023 | Abstract similar documents |
| article Editorial | ||
| "... options for the treatment of chronic cerebral ischemia (CCI), one of the most common causes of vascular ..." | ||
| Vol 13, No 1 (2021) | Cognitive impairment in COVID-19 survivors | Abstract similar documents |
| T. M. Ostroumova, P. A. Chernousov, I. V. Kuznetsov | ||
| "... The neurological manifestations of the novel coronavirus COVID-19 infection caused by SARS-CoV-2 ..." | ||
| Vol 17, No 3 (2025) | Neurological masks of post-COVID syndrome | Abstract similar documents |
| O. N. Voskresenskaya, A. A. Kulesh, N. V. Lebedeva, A. B. Lokshina, D. A. Grishina, А. V. Peretechikova, O. V. Kolokolov, V. A. Parfenov | ||
| "... Post-COVID syndrome (PCS) refers to a constellation of signs and symptoms that develop during ..." | ||
| Vol 12, No 1 (2020) | The efficacy and safety of ethyl methyl hydroxypyridine succinate used as part of sequential therapy in patients with chronic cerebral ischemia | Abstract similar documents |
| V. V. Burdakov, D. V. Krasnykh | ||
| "... cerebral ischemia (CCI) in the presence of hypertension and atherosclerosis. Patients and methods ..." | ||
| Vol 13, No 3 (2021) | Post-covid syndrome: a review of pathophysiology, neuropsychiatric manifestations and treatment perspectives | Abstract PDF (Eng) similar documents |
| D. R. Khasanova, Yu. V. Zhitkova, G. R. Vaskaeva | ||
| "... In the context of the COVID-19 pandemic, healthcare is faced with several new problems, one ..." | ||
| Vol 10, No 1 (2018) | Possible mechanisms of cognitive dysfunction in patients with chronic forms of cerebrovascular diseases | Abstract similar documents |
| O. N. Voskresenskaya, N. B. Zakharova, Yu. S. Tarasova, N. E. Tereshkina, V. A. Perepelov, E. M. Perepelova | ||
| "... (CCI). However, the role of the mechanisms of inflammation and angiogenesis in the origin of CI ..." | ||
| Vol 13, No 5 (2021) | Impact of mental disorders on COVID-19 outcomes | Abstract similar documents |
| N. N. Petrova, V. E. Pashkovskiy, M. S. Sivashova, A. N. Gvozdetsky, G. A. Prokopovich | ||
| "... and COVID-19 and to identify on their basis predictors of poor outcomes associated with mental state ..." | ||
| Vol 13, No 3 (2021) | COVID-19 and epilepsy: Russian and international experience | Abstract similar documents |
| G. V. Odintsova | ||
| "... This article reviews the issues of epilepsy course in patients with COVID-19 and predictors ..." | ||
| Vol 14, No 1 (2022) | COVID-19 associated multiple cranial neuropathies | Abstract similar documents |
| M. Yu. Maksimova, Ya. O. Grusha, E. I. Fettser | ||
| "... cranial nerves involvement (for example, VII, VI, and III) has been described. Patients with COVID-19 ..." | ||
| Vol 14, No 2 (2022) | Post-COVID pain syndrome: a review of international observations | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Bokova, N. I. Shavlovskiy | ||
| "... The novel coronavirus infection is commonly referred to as COVID-19, sometimes by the name ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Acute inflammatory demyelinating pseudotumor after COVID-19 | Abstract similar documents |
| T. I. Yakushina, D. M. Yakushin, I. O. Shtang | ||
| "... recovered from COVID-19, in whom an MRI revealed a large single focus in the left frontal lobe with signs ..." | ||
| Vol 13, No 5 (2021) | Management of patients with pain syndromes associated with COVID-19 | Abstract similar documents |
| L. T. Akhmedzhanova, T. M. Ostroumova, O. A. Solokha | ||
| "... and systems. Myalgias and arthralgias and, in particular, back pain are common symptoms of COVID-19 and can ..." | ||
| Vol 12, No 6 (2020) | COVID-19 and mental health: challenges and first conclusions | Abstract similar documents |
| V. E. Medvedev, O. A. Dogotar | ||
| "... Under the conditions of the COVID-19 pandemic, a rapid change in the epidemiological situation ..." | ||
| Vol 13, No 2 (2021) | Anxiety and depression in COVID-19: treatment options | Abstract similar documents |
| V. E. Medvedev | ||
| "... During the examination of post-COVID patients, a direct and indirect negative effect of COVID-19 ..." | ||
| Vol 13, No 2 (2021) | COVID-19 vaccination guidelines for patients with multiple sclerosis | Abstract similar documents |
| N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko | ||
| "... The opinion of Russian experts on the possibility of COVID-19 vaccination in patients ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Review of human interferons and the potential of their use in the complex therapy of a new coronavirus infection COVID-19 | Abstract similar documents |
| E. V. Granatov, A. R. Abashev, F. A. Khabirov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... effective and specific drugs have found their place in the treatment of such diseases. As the COVID-19 (SARS ..." | ||
| Vol 12, No 3 (2020) | The first experience with Angiovit in the combination treatment of acute COVID-19 infection | Abstract similar documents |
| A. N. Boyko, N. A. Shamalov, O. V. Boyko, E. E. Arinina, O. V. Lyang, E. A. Dubchenko, A. V. Ivanov, A. A. Kubatiev | ||
| "... On March 11, 2020, the WHO announced the COVID-19 outbreak a pandemic. The disease was established ..." | ||
| Vol 13, No 2 (2021) | Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions | Abstract similar documents |
| V. A. Golovacheva, G. R. Tabeeva, I. V. Kuznetsov | ||
| "... 2019 (COVID-19). Among the pathogenetic mechanisms, the neurotropicity of the SARS- CoV-2 virus ..." | ||
| Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
| A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
| "... Post-COVID syndrome can develop in all patients who have had COVID-19, regardless of the disease ..." | ||
| Vol 14, No 1 (2022) | COVID 19 in a family with rare genetic disease of the nervous system | Abstract PDF (Eng) similar documents |
| M. Yu. Martynov, V. A. Kutashov, O. V. Ulyanova | ||
| "... We present familial tuberous sclerosis (TS) case complicated by COVID-19. COVID-19 aggravates ..." | ||
| Vol 13, No 6 (2021) | Causes and predictors of mental disorders during the COVID-19 pandemic | Abstract PDF (Eng) similar documents |
| N. A. Tyuvina, V. O. Vysokova, T. N. Maksimova, S. V. Prokhorova | ||
| "... The ongoing pandemic of the new coronavirus infection COVID-19, the increase in the number ..." | ||
| Online-first | Ведение пациентов с болевыми синдромами на фоне COVID-19 | Abstract similar documents |
| L. Т. Аkhmedzhanova, T. M. Ostroumova, O. A. Solokha | ||
| "... The disease caused by COVID-19 is multi-organ and involves almost all organs and systems. Myalgias ..." | ||
| Vol 13, No 1 (2021) | Depression during the COVID-19 pandemic (analysis of clinical cases) | Abstract similar documents |
| I. Yu. Dorozhenok | ||
| "... the predictors of their development during the pandemic, there are COVID-19 symptoms, a history of mental ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Nervous system damage in COVID-19 with an emphasis on the management of patients with multiple sclerosis | Abstract similar documents |
| A. N. Boyko, S. A. Sivertseva, N. N. Spirin | ||
| "... The main target for COVID-19 is the lung with the development of acute respiratory failure ..." | ||
| Vol 15, No 6 (2023) | Admitting a patient with musculoskeletal pain following COVID-19 disease | Abstract similar documents |
| I. D. Romanov, O. A. Shavlovskaya, I. A. Bokova | ||
| "... A significant proportion of patients who have had COVID-19 continue to suffer from persistent ..." | ||
| Vol 16, No 1 (2024) | Acute cerebrovascular accidents in patients with new coronavirus infection COVID-19 | Abstract similar documents |
| N. A. Shamalov, L. V. Klimov, M. A. Soldatov, T. V. Kiseleva, V. N. Shamalova, N. A. Marskaya, O. V. Lyang | ||
| "... The incidence of neurological complications in COVID-19 can reach 8–10% of all cases of new ..." | ||
| Vol 13, No 6 (2021) | Role of chondroitin sulfate in the regulation of neuroimmunoendocrine network interactions in patients with neurological symptoms in the post-covid period | Abstract similar documents |
| I. V. Sarvilina, O. A. Gromova, M. Yu. Maksimova, M. N. Sharov, Yu. S. Prokofyeva | ||
| "... of neuroimmunoendocrine network interactions in long-term COVID-19 are considered. Modern data on the relationship ..." | ||
| Vol 14, No 1 (2022) | Validation of the Russian version of Stress and Anxiety to Viral Epidemics – 9 items (SAVE-9) among healthcare workers during COVID-19 pandemic | Abstract similar documents |
| E. S. Mosolova, S. Chung, D. N. Sosin, S. N. Mosolov | ||
| "... Over the past two years, healthcare workers have been daily saving patients diagnosed with COVID ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic | Abstract similar documents |
| E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, I. D. Stolyarov | ||
| "... The spread of the COVID-19 pandemic posed a serious challenge for scientific and clinical medical ..." | ||
| Vol 13, No 5 (2021) | Pathobiochemical pathways of redox imbalance in the neurological long-term effects of COVID-19 and the role of chondroitin sulfate in the redox status restoration | Abstract similar documents |
| I. V. Sarvilina, O. A. Gromova, A. V. Naumov | ||
| "... The review examines the epidemiology and clinical manifestations of COVID-19 long-term ..." | ||
| Vol 14, No 4 (2022) | Cognitive impairment in patients with coronavirus infection | Abstract similar documents |
| Y. A. Starchina, O. V. Kosivtsova | ||
| "... COVID-19, memantine (akatinol memantine) is recommended. ..." | ||
| Vol 15, No 6 (2023) | Neurohumoral gate for the entry of coronavirus into the central nervous system through the cribriform plate of the skull | Abstract similar documents |
| V. N. Nikolenko, M. V. Oganesyan, N. A. Rizaeva, A. T. Nikitina, M. P. Pavliv, А. V. Polyakova, E. A. Sozonova, M. N. Khabibov | ||
| Vol 16, No 3 (2024) | Impact of COVID-19 on mild vascular cognitive impairment in patients with atrial fibrillation: results of a three-year observational study | Abstract similar documents |
| O. V. Vorob'eva, N. N. Shindryaeva, V. V. Fateeva | ||
| "... of COVID-19. Objective: to investigate the impact of COVID-19 on the dynamics of cognitive status ..." | ||
| Vol 16, No 6 (2024) | Antidepressant and anxiolytic efficacy and tolerability of agomelatine in the treatment of depression after COVID-19 in daily clinical practice (non-interventional study TELESPHOR) | Abstract similar documents |
| V. E. Medvedev, A. N. Bogolepova, D. P. Morozov, B. B. Kvasnikov | ||
| "... Depression and anxiety are among the most common disorders observed in patients after COVID-19 ..." | ||
| Vol 13, No 1 (2021) | Anxiety: phenomenology, epidemiology, and risk factors during the novel coronavirus SARS-CoV-2 (COVID-19) pandemic | Abstract similar documents |
| A. G. Merkin, S. S. Akinfieva, A. V. Martyushev-Poklad, O. P. Beloskurskaya, E. N. Dinov, S. L. Ostrovsky, A. N. Komarov, O. Yu. Zakharova, V. A. Kazhin, I. A. Nikiforov, M. Glover | ||
| "... The COVID-19 coronavirus pandemic in 2020 led to significant negative social consequences ..." | ||
| Vol 14, No 6 (2022) | A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study | Abstract similar documents |
| Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova | ||
| "... Amantadine has begun to be used as a possible alternative in COVID-19 therapy to mitigate its ..." | ||
| Vol 13, No 6 (2021) | Multifactorial model of willingness to get vaccinated in medical students during 3rd wave of COVID-19 pandemic | Abstract PDF (Eng) similar documents |
| V. L. Malygin, Ya. V. Malygin, A. S. Iskandirova, E. E. Pahtusova, Yu. A. Merkuryeva, V. V. Ogarev, A. V. Hudiakov, M. A. Asasian | ||
| "... Vaccination of the population is the most essential and decisive measure in overcoming the COVID ..." | ||
| Vol 12, No 6 (2020) | Somatization disorders of affective and neurotic registers during the COVID-19 pandemic (analysis of clinical cases) | Abstract similar documents |
| I. Yu. Dorozhenok | ||
| "... The COVID-19 coronavirus pandemic has added additional difficulties to the differential diagnostic ..." | ||
| Vol 15, No 2 (2023) | Clinical course and diagnosis of cerebral vein and sinus thrombosis associated with COVID-19 in young and middle-aged patients | Abstract similar documents |
| E. G. Klocheva, V. V. Goldobin, F. Z. Olimova | ||
| "... . In the era of the COVID-19 pandemic, there is a steady increase in CVT (4.2% vs. 0.5–1%). At the same time ..." | ||
| Vol 16 (2024): (Suppl. 2) | Results of tele-rehabilitation in patients with multiple sclerosis during 2020–2021 COVID-19 pandemic | Abstract similar documents |
| S. A. Sivertseva, K. S. Anfilofeva, A. V. Zotova, V. D. Chukreev, A. Yu. Belkina, L. I. Volkova, M. E. Guseva, A. N. Boyko | ||
| Vol 13, No 5 (2021) | Obsessive-compulsive disorder during the SARS-CoV-2 pandemic (case report) | Abstract PDF (Eng) similar documents |
| N. A. Tiuvina, T. N. Maksimova, S. V. Prokhorova, V. O. Vysokova | ||
| "... The novel coronavirus 2019 (COVID-19) pandemic has affected not only the somatic health of people ..." | ||
| Vol 14, No 4 (2022) | Clinical features of mental disorders during the pandemic of a new coronavirus infection | Abstract similar documents |
| N. A. Tyuvina, V. O. Vysokova, E. N. Efremova, O. V. Lavrinenko | ||
| "... COVID-19, there is still insufficient data on the impact of the global pandemic on people's mental ..." | ||
| 1 - 70 of 85 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
